# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-036529
Filing Date
2024-08-09
Accepted
2024-08-09 17:03:13
Documents
58
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | cpix-20240630.htm iXBRL | 10-Q | 821555
2 | EX-31.1 | a2024q2-exhibit311.htm | EX-31.1 | 12674
3 | EX-31.2 | a2024q2-exhibit312.htm | EX-31.2 | 12667
4 | EX-32.1 | a2024q2-exhibit321.htm | EX-32.1 | 6873
| Complete submission text file | 0001628280-24-036529.txt |  | 4353343

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cpix-20240630.xsd | EX-101.SCH | 31616
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | cpix-20240630_cal.xml | EX-101.CAL | 50455
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | cpix-20240630_def.xml | EX-101.DEF | 114773
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | cpix-20240630_lab.xml | EX-101.LAB | 429603
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | cpix-20240630_pre.xml | EX-101.PRE | 290934
60 | EXTRACTED XBRL INSTANCE DOCUMENT | cpix-20240630_htm.xml | XML | 464289

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 241193852
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)